MAIL MAN

[righty]

VIVK.ob - Gapping up to .29 on Morning News
Mon, December 14, 2009 7:20:03 AMFrom: Anthony Watson <[e-mail]>Add to Contacts



--------------------------------------------------------------------------------

In case you missed it....

VIVK came out with another hot piece of press this morning.

VIVK looks ready to start the day with serious upward momentum.


Check it out below:

Vivakor Announces Launch of VivaThermic Website and Highlights Distribution & Sales of Its VivaThermic Products in Japan Through Veritas Corporation

CORALVILLE, Iowa, Dec. 14 /PRNewswire-FirstCall/ -- Vivakor, Inc. (OTC Bulletin Board: VIVK.OB) today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com. In addition to providing customers with the latest news and developments for its VivaThermic product line, Vivakor developed this site to be a valuable resource for its domestic and international customers, such as the highly respected Veritas Corporation of Tokyo, Japan, which signed an exclusive five year exclusive distribution agreement to distribute Vivakor's VivaThermic products in Japan. Under the terms of the Agreement, Veritas will have exclusive distribution rights to all Vivakor's VivaThermic Division products in Japan, including the recently released VivaThermic SUPER-150 and VivaThermic UTLRA-300 cryovials.

Mr. Shinsaku Iida, President of Veritas Corporation, stated: "As a leading distributor of a biotech products in Japan, including capital equipment, reagents, and kits to support research in the fields of genomics, proteomics, and metabolomics, we believe we are the perfect partner for Vivakor and their VivaThermic product line. In Japan, as in the rest of the world, there is a real need for better sample preparation methods that will allow for the safe, rapid, and reliable sample preservation from a variety of biomaterials. We are very impressed with new Ultra CryoVials, believe that it is the best system available for sample preservation, and believe that we will be very successful in placing the entire cryo-preservation system in the Japanese market as 21 century's gold standard."

Vivakor's CEO, Dr. Tannin Fuja, indicated that, "We are pleased to launch the VivaThermic website that will not only promote domestic distribution but assist our international distributors. We are also pleased to partner with the highly-respected Japanese corporation, Veritas, to distribute our superior VivaThermic products. The Japanese biotechnology industry is one of the leading participants in the global biotech market. Japan, with its family of industry leading biotechnology companies, continues to lead in this increasingly global market."

About Vivakor

Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

About Veritas Corporation

Veritas is a trusted distributor of cutting edge products from around the world to the Japanese life science community. Established in 1972, Veritas is well known for superior technical support and knowledgeable sales and marketing staff. In addition to Vivakor's VivaThermic products, Veritas represents prestigious suppliers from USA, Canada, Germany, England, Sweden, Italy, New Zealand, China, and India for life science products. Veritas specializes in cell biology (including stem cell biology), immunology, hematology and microbiology, as well as to sophisticated scientific instruments and niche services.


Previously sent Information below:




VIVK came out with big news this morning and the market responded.

VIVK ran from .21 to a High of Day at .359 and a close at .27.

VIVK had a High of Day up of 75% from out alert on news this morning.

VIVK closed up 22% and there appears to be More Profits to Come!


Continue your research and start the profit potential with VIVK (read below):


Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products

CORALVILLE, Iowa, Dec. 10 /PRNewswire-FirstCall/ -- Vivakor, Inc. (OTC Bulletin Board: VIVK.OB) today announced that it has entered into an exclusive, $5 million license agreement with consumer product specialist, Regeneca International, Inc. (www.regeneca.com). The agreement exclusively licenses to Regeneca distribution rights to a new cutting-edge nutraceutical formulation developed by Vivakor and provides for the development of future formulations by Vivakor for Regeneca. Under the terms of the agreement, Regeneca shall be the exclusive worldwide direct-to-consumer distributor for the current formulation as well as any future nutraceutical formulations offered to Regeneca by Vivakor. Regeneca has committed to purchase from Vivakor a minimum of $5 million in product over the next three years and Vivakor will receive a 15% ownership interest in Regeneca's outstanding common stock and will be the exclusive supplier of the licensed product to Regeneca.

Read the full news @ http://finance.yahoo.com/news/Vivakor-Receives-5-Million-prnews-1162304467.html?x=0&.v=1



Vivakor Inc. (VIVK.ob) Bounce Alert

Vivakor Inc. (VIVK.ob) has now entered our radar and being placed on our prestigious bounce alert watch!!!

After its initial run up on strong volume in late October, the stock has settled into a base. Volume in recent days has slowed as we see support at this level; the price stability has allowed for some of the technical indicators to improve. The shares seem poised for a reversal to the upside after coming back towards their initial breakout point. The recent share gains have allowed toxic share positions to find their way out of the stock and initialize a clean slate for the next big move!!!

VIVK has been releasing BIG NEWS these past weeks creating huge buzz in the investing world. Their most recent news released Tuesday announced the procedure for how shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmerica, Inc. Each Vivakor shareholder will be entitled to receive one share of HealthAmeria common stock for each share of Vivakor common stock beneficially owned on December 1, 2009. This news has pleased the Company’s shareholders and has only improved their situation as a growing company going into the future!!!

About Vivakor, Inc. (VIVK.ob)


Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research
that develops and acquires products in the fields of molecular medicine, electro-optics,
biological handling and natural and formulary compounds, that extend or improve
life. The R&D Core at Vivakor (the idea hub) innovates, develops and validates biomedical
devices and biotechnologies. Commercialization of Vivakor technologies is accomplished
through partnerships with manufacturers and niche-industry marketing and distribution
leaders. Vivakor generates revenues through the licensing or sale of its technologies.
Vivakor is preparing a portfolio of intellectual properties and subsidiaries. The
subsidiaries will focus on the commercialization of technologies developed by Vivakor.

More information can be found about Vivakor (VIVK) at www.vivakor.com



Regards,
PSP Staff







_____________________________________________________________________________





The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Release of Liability: Through use of this website viewing or using you agree to hold Thepennystockpicks.com which is owned and operated by Thepennystockpicks.com.com and its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.

Thepennystockpicks.com is written and published by Thepennystockpicks.com.com employees. Readers are advised that this analysis report is issued solely for informational purposes. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Thepennystockpicks.com.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice.

All information on featured companies is provided by the companies profiled, or is available from public sources and Thepennystockpicks.com.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Thepennystockpicks.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Thepennystockpicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. Thepennystockpicks.com has also been advised that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in or der to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Thepennystockpicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Thepennystockpicks.com. Thepennystockpicks.com owners may or may not hold positions in the companies that are profiled. Investing in securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled .

For a full disclaimer, visit http://www.thepennystockpicks.com/disclaimer/

For your further information, Thepennystockpicks.com has agreed to be compensated one hundred thousand dollars for a one month investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Vivakor Inc.

Third Party Web Sites and Information Thepennystockpicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. Thepennystockpicks.com.com does not control, endorse, or guarantee content found in such sites. You agree that Thepennystockpicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that Thepennystockpicks.com. shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.